As Prof. Joanna Zajkowska says, the COVID-19 pandemic is not over yet. Only the global threat has ended. The virus is still present and transmitting, and can also evolve. It is particularly dangerous for immunocompetent people. Vaccines are constantly being improved, and one is being prepared that will protect against the entire omicron mutation family. The vaccine, while significantly reducing the risk of infection, does not protect against it completely. Therefore, it is also very important to use therapy to fight the virus after infection.
- By reducing its amount, our immune system can better cope with the disease. The less virus, the less malignant the symptoms and the lower the risk of complications. So both are extremely important, especially when it comes to risk groups that for some reason will not respond to vaccination. These are oncology patients, those on biologic or immunosuppressive treatment. The sequelae of COVID-19 disease can be immunological, cardiovascular, but also related to diabetes, parkinsonism," points out Prof. Zajkowska.
The oral anti-COVID-19 drug consists of two active substances. When used together, they very effectively block the viral protease enzyme that coronavirus uses for its replication. It is due to this that it...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
